Mitomycin C primary trabeculectomy with releasable sutures in primary glaucoma

dc.contributor.authorÜnlü, K
dc.contributor.authorAksünger, A
dc.contributor.authorSöker, S
dc.contributor.authorErtem, M
dc.date.accessioned2024-04-24T16:18:40Z
dc.date.available2024-04-24T16:18:40Z
dc.date.issued2000
dc.departmentDicle Üniversitesien_US
dc.descriptionXXXIInd National Congress of the Turkish-Society-of-Ophthalmology -- SEP, 1998 -- BURSA, TURKEYen_US
dc.description.abstractPurpose: To evaluate the effects of mitomycin C and a releasable suture technique on outcomes of primary trabeculectomy in primary glaucoma patients. Methods: A prospective analysis of patients who underwent primary trabeculectomy with a mitomycin C concentration of 0.2 mg/mL for 2 minutes. For closing the scleral flap, releasable sutures were used in 18 patients (17 eyes), Group 1, or permanent sutures in 18 patients (20 eyes), Group 2. Clinical outcome factors including postoperative intraocular pressure (IOP), visual acuity, and incidence of complications were determined. Results: The mean follow-up periods were 8.1 +/- 1.3 months in Group 1 and 8.3 +/- 1.3 months in Group 2. The postoperative reduction in IOP was highly significant (P < .0001) at all time intervals in both groups. In all measurement of IOP before the second week, mean IOP in Group 2 was found significantly lower than the mean IOP in Group 1 (P = .01). No statistically significant differences were found between the groups at later mean IOP measurements. At the last visit, the complete success rate was 88.8% in Group 1 and 85.0% in Group 2. No serious complications such as hypotonous maculopathy were observed in ally patient. Conclusion: Primary trabeculectomy with mitomycin C in eyes with primary glaucoma showed effective IOP pressure reduction. There were no cases of serious complications. In the early postoperative period IOP was controlled better in the releasable suture group. (C) 2000 Japanese Ophthalmological Society.en_US
dc.description.sponsorshipTurkish Soc Ophthalmolen_US
dc.identifier.doi10.1016/S0021-5155(00)00221-5
dc.identifier.endpage529en_US
dc.identifier.issn0021-5155
dc.identifier.issue5en_US
dc.identifier.pmid11033132en_US
dc.identifier.scopus2-s2.0-0342572594en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage524en_US
dc.identifier.urihttps://doi.org/10.1016/S0021-5155(00)00221-5
dc.identifier.urihttps://hdl.handle.net/11468/16221
dc.identifier.volume44en_US
dc.identifier.wosWOS:000089835400013
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJapanese Journal of Ophthalmologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMitomycin Cen_US
dc.subjectPrimary Trabeculectomyen_US
dc.subjectReleasable Sutureen_US
dc.subjectUncomplicated Glaucomaen_US
dc.titleMitomycin C primary trabeculectomy with releasable sutures in primary glaucomaen_US
dc.typeConference Objecten_US

Dosyalar